Silco Pharmaceuticals Limited (DSE:SILCOPHL)

Silco Pharmaceuticals Revenue

Silco Pharmaceuticals had revenue of 116.05M BDT in the quarter ending September 30, 2025, with 24.65% growth. This brings the company's revenue in the last twelve months to 432.89M, up 5.56% year-over-year. In the fiscal year ending June 30, 2025, Silco Pharmaceuticals had annual revenue of 431.54M with 5.23% growth.

• Revenue (ttm): 432.89M
• Revenue Growth: +5.56%
• P/S Ratio: 3.33
• Revenue / Employee: 1.38M
• Employees: 313
• Market Cap: 1.44B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2025	431.54M	21.44M	5.23%
Jun 30, 2024	410.10M	-54.59M	-11.75%
Jun 30, 2023	464.70M	-94.77M	-16.94%
Jun 30, 2022	559.47M	-41.59M	-6.92%
Jun 30, 2021	601.06M	-132.59M	-18.07%